On-going clinical trials investigating the role of gasdermins in cancer are currently undergoing, including the analysis of GSDMD cleavage in cutaneous T-cell lymphoma (NCT05333367), and another is investigating GSDMD and inflammasome activation in acute myeloid leukemia patients (NCT06200441). This evidence concerns the gene GSDMD and acute myeloid leukemia.